Ad-hoc Messages 2011

Here you find Ad-hoc messages of year 2011.

To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.

2011
September 29, 2011

Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint

Download ( PDF, 87 KB ) collect

September 6, 2011

Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban

Download ( PDF, 124 KB ) collect

 

Investor News issued in year 2011 can be found here.

Publications of the previous years are offered in the Archive Overview.

Last updated: November 20, 2013 Copyright © Bayer AG